Our data indicated that estrogen-mediated inhibition of p53 in H1299L858R cancer cells changed the protein composition (FGF2, GDF15, IGFBP2, CCL5, PTX3, VEGF, and MMP9) of conditioned medium. This evidence concerns the gene CCL5 and cancer.